PFNX +27%/AH on positive data for Forteo “FoB”: https://www.prnewswire.com/news-releases/pfenex-announces-positive-top-line-pf708-study-results-in-osteoporosis-patients-on-track-for-submission-of-new-drug-application-in-third-quarter-2018-300647961.html “FoB” is in quotation marks because the FDA regulates Forteo as a small-molecule drug rather than a biologic.